© 1996 Oxford University Press
research-article |
CARCINOGENESIS: Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle
Departments of Pharmacology, The George Washington University Medical Center 2300 I Street NW, Washington, DC 20037
1Departments of Pathology, The George Washington University Medical Center 2300 I Street NW, Washington, DC 20037
2Oncology Division, Beth Israel Hospital and Harvard Medical School 330 Brookline Avenue, Boston, MA 02215, USA
3To whom correspondence should be addressed
Previous studies have shown that in vitro treatment of a synthetic double-stranded DNA template with chro-mium(IH), or chromium(VI) in the presence of ascorbate, resulted in guanine-specific DNA polymerase arrests that correlated strongly with DNA-DNA cross-linking. In vivo chromium(VI) undergoes a more complicated intra-cellular cascade of reductive metabolism than is achievable in an in vitro model. Moreover, in living cells, DNA is highly packaged in the form of chromatin which may alter the accessibility of DNA to chromium. A repetitive primer-extension assay was employed to determine whether chromium forms polymerase-arresting lesions in vivo. Normal human lung fibroblasts treated with chromium(VI) exhibited adduct levels of 0.13–0.92 mmol Cr/mol DNA-nucleotides in the total genome (0.26–1.84 Cr adducts/Kbp DNA) and DNA interstrand cross-links. Genomic DNA was isolated and alphoid sequences (1–5% of the genome) were used as a substrate for repetitive primer extension using Taq polymerase. The results showed a dose-dependent, guanine-specific, replication termination, even at low doses resulting in greater than 90% survival. The same treatment resulted in a dose-dependent suppression of thymidine incorporation into DNA immediately after treatment Thymidine incorporation increased during the first 6 h after the 2-h exposure, probably related to the repair of single strand breaks, but then returned to high suppression levels at 24 h. The chromate treatments inhibited cell growth by specific blocking of the progression of cells through S-phase of the cell cycle. The results confirmed our studies in cell-free systems and taken together they strongly indicate that guanine-guanine DNA interstrand cross-links induced by chromate in living cells is the lesion responsible for blocking DNA replication processivity.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F.-J. Liu, A. Barchowsky, and P. L. Opresko The Werner Syndrome Protein Functions in Repair of Cr(VI)-Induced Replication-Associated DNA Damage Toxicol. Sci., August 1, 2009; 110(2): 307 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Keegan, I. D. Learmonth, and C. P. Case Orthopaedic metals and their potential toxicity in the arthroplasty patient: A REVIEW OF CURRENT KNOWLEDGE AND FUTURE STRATEGIES J Bone Joint Surg Br, May 1, 2007; 89-B(5): 567 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Priester, S. G. Olson, S. M. Webb, M. P. Neu, L. E. Hersman, and P. A. Holden Enhanced Exopolymer Production and Chromium Stabilization in Pseudomonas putida Unsaturated Biofilms. Appl. Envir. Microbiol., March 1, 2006; 72(3): 1988 - 1996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Davies, A. Sood, A. C. Lewis, R. Newson, I. D. Learmonth, and C. P. Case Metal-specific differences in levels of DNA damage caused by synovial fluid recovered at revision arthroplasty J Bone Joint Surg Br, October 1, 2005; 87-B(10): 1439 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ha, S. Ceryak, and S. R. Patierno Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of {gamma}-H2AX Carcinogenesis, November 1, 2004; 25(11): 2265 - 2274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ha, S. Ceryak, and S. R. Patierno Chromium (VI) Activates Ataxia Telangiectasia Mutated (ATM) Protein. REQUIREMENT OF ATM FOR BOTH APOPTOSIS AND RECOVERY FROM TERMINAL GROWTH ARREST J. Biol. Chem., May 9, 2003; 278(20): 17885 - 17894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Feng, W. Hu, W. N. Rom, M. Costa, and M.-S. Tang Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells Carcinogenesis, April 1, 2003; 24(4): 771 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.J. Hodges, B. Adam, A.J. Lee, H.J. Cross, and J.K. Chipman Induction of DNA-strand breaks in human peripheral blood lymphocytes and A549 lung cells by sodium dichromate: association with 8-oxo-2-deoxyguanosine formation and inter-individual variability Mutagenesis, November 1, 2001; 16(6): 467 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Pritchard, S. Ceryak, L. Ha, J. L. Fornsaglio, S. K. Hartman, T. J. O'Brien, and S. R. Patierno Mechanism of Apoptosis and Determination of Cellular Fate in Chromium(VI)-exposed Populations of Telomerase-immortalized Human Fibroblasts Cell Growth Differ., October 1, 2001; 12(10): 487 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Pritchard, J. Singh, D. L. Carlisle, and S. R. Patierno Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells Carcinogenesis, November 1, 2000; 21(11): 2027 - 2033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Waalkes, D. A. Fox, J. C. States, S. R. Patierno, and M. J. McCabe Jr. Metals and Disorders of Cell Accumulation: Modulation of Apoptosis and Cell Proliferation Toxicol. Sci., August 1, 2000; 56(2): 255 - 261. [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Chuang, G.-Y. Liou, and J.-L. Yang Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity Carcinogenesis, August 1, 2000; 21(8): 1491 - 1500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Carlisle, D. E. Pritchard, J. Singh, B. M. Owens, L. J. Blankenship, J. M. Orenstein, and S. R. Patierno Apoptosis and P53 Induction in Human Lung Fibroblasts Exposed to Chromium (VI): Effect of Ascorbate and Tocopherol Toxicol. Sci., May 1, 2000; 55(1): 60 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Shumilla, R. J. Broderick, Y. Wang, and A. Barchowsky Chromium(VI) Inhibits the Transcriptional Activity of Nuclear Factor-kappa B by Decreasing the Interaction of p65 with cAMP-responsive Element-binding Protein-binding Protein J. Biol. Chem., December 17, 1999; 274(51): 36207 - 36212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. P. Yuann, K. J. Liu, J. W. Hamilton, and K. E. Wetterhahn In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium–DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of Osteogenic Disorder Shionogi rats following treatment with chromium(VI) Carcinogenesis, July 1, 1999; 20(7): 1267 - 1275. [Abstract] [Full Text] [PDF]
|
|